Cargando…
Anticoagulant properties of drotrecogin alfa (activated) during hemofiltration in patients with severe sepsis
In a retrospective study among 35 severely septic patients treated with drotrecogin alfa (activated) (DrotAA) and renal replacement therapy (RRT), Camporota and colleagues demonstrated that the addition of heparin, epoprostenol, or both to DrotAA during RRT did not improve filter survival. Furthermo...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688108/ https://www.ncbi.nlm.nih.gov/pubmed/19226446 http://dx.doi.org/10.1186/cc7684 |